Demiray, M. Et Al. 2005. Phase II study of gemcitabine plus paclitaxel in metastatic breast cancer patients with prior anthracycline exposure. CANCER INVESTIGATION , vol.23, no.5 , 386-391.

Demiray, M., Kurt, E., Evrensel, T., Kanat, O., Arslan, M., Saraydaroglu, O., ... Ercan, K.(2005). Phase II study of gemcitabine plus paclitaxel in metastatic breast cancer patients with prior anthracycline exposure. CANCER INVESTIGATION , vol.23, no.5, 386-391.

Demiray, M Et Al. "Phase II study of gemcitabine plus paclitaxel in metastatic breast cancer patients with prior anthracycline exposure," CANCER INVESTIGATION , vol.23, no.5, 386-391, 2005

Demiray, M Et Al. "Phase II study of gemcitabine plus paclitaxel in metastatic breast cancer patients with prior anthracycline exposure." CANCER INVESTIGATION , vol.23, no.5, pp.386-391, 2005

Demiray, M. Et Al. (2005) . "Phase II study of gemcitabine plus paclitaxel in metastatic breast cancer patients with prior anthracycline exposure." CANCER INVESTIGATION , vol.23, no.5, pp.386-391.

@article{article, author={M Demiray Et Al. }, title={Phase II study of gemcitabine plus paclitaxel in metastatic breast cancer patients with prior anthracycline exposure}, journal={CANCER INVESTIGATION}, year=2005, pages={386-391} }